VALIANTLAB vs VINEETLAB: Stock Comparison

Valiant Laboratories Limited vs Vineet Laboratories Limited

Live data: 29 April 2026, 4:01 PM IST • Source: NSE and company filings

Valiant Laboratories Limited is the larger company by market capitalisation. Valiant Laboratories Limited shows lower leverage, a higher ROCE and a higher net margin, while Vineet Laboratories Limited shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Valiant Laboratories Limited and Vineet Laboratories Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, VALIANTLAB is more favourable on 7 of 10 scored metrics and VINEETLAB on 1These counts are context-free and are not an overall rating.

Key Differences

Market Cap
VALIANTLAB is the larger company
₹329 Cr vs ₹75 Cr
EPS
VALIANTLAB has higher earnings per share
₹-0.05 vs ₹-20.47
Revenue Growth (TTM YoY)
VINEETLAB has faster revenue growth
11.05% vs 0%
Qtr Sales Growth
VALIANTLAB has stronger quarterly sales growth
148% vs -68.8%
Qtr Profit Growth
VALIANTLAB has stronger quarterly profit growth
457% vs 59.2%
ROCE
VALIANTLAB has a higher ROCE
-0.95% vs -28%
Net Margin
VALIANTLAB has a higher net margin
-1.38% vs -26.92%
Operating Margin
VALIANTLAB has a higher operating margin
1.12% vs -22.4%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricVALIANTLABVINEETLAB
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricVALIANTLABVINEETLAB
Live Price₹81.65₹38.55
Day Change2.55%5.79%
Volume87,4892.02 L
52-Week High₹100.98₹49.99
52-Week Low₹49.51₹27.96
Distance from 52W High-19.14%-22.88%

Valuation

MetricVALIANTLABVINEETLAB
Market Cap₹329 Cr₹75 Cr
P/E Ratio-101.03x
P/B Ratio1.06x
EPS₹-0.05₹-20.47
Book Value₹50.08₹15.84
Dividend Yield0%0%

Growth

MetricVALIANTLABVINEETLAB
Revenue Growth (TTM YoY)0%11.05%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth148%-68.8%
Qtr Profit Growth457%59.2%

Profitability & Leverage

MetricVALIANTLABVINEETLAB
ROE-1.05%
ROCE-0.95%-28%
Net Margin-1.38%-26.92%
Operating Margin1.12%-22.4%
Debt to Equity0.14x2.73x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricVALIANTLABVINEETLAB
Promoter Holding74.94%5.98% 6.48 pp
FII Holding0% 0.2 pp0.36% 0.36 pp
DII Holding0%
Public Holding25.06% 0.2 pp93.66% 6.12 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Valiant Laboratories Limited and Vineet Laboratories Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.